Pierandrea Muglia

CMO at Saniona

Speaker

Pierandrea Muglia, M.D., is Chief Medical Officer at Saniona, a Danish biotech listed on Nasdaq Stockholm (SANION). He previously served as President and Founder of GRIN Therapeutics, CMO at Handl Therapeutics, VP of Neurology Early Clinical Development at UCB, VP of Clinical Development at NeuroSearch, and Director of Translational Medicine at GSK. Clinically trained in neuropsychiatry, Dr. Muglia has over 30 years of experience in neuroscience R&D and has led the development of numerous drug candidates across neurological and psychiatric indications in both pharma and biotech settings.